New Prenylated Isoflavonoids From Erythrina addisoniae With Anti‐Neuroinflammatory Activity via Nuclear Factor Kappa‐Light‐Chain‐Enhancer of Activated B Cells Pathway Suppression
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202503261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Jin-Pyo An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Erythrina, NF-kappa B, Isoflavones, Anti-Inflammatory Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Basic Science Research Programs, National Research Foundation of Korea, Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT in Korea.
Abstract (Originalsprache)
Recent investigations have identified prenylated isoflavonoids as major constituents of Erythrina addisoniae , yet their anti‐neuroinflammatory potential remains unexplored. Through bioassay‐guided isolation, two new prenylated isoflavonoids ( 1 and 2 ), along with nine known compounds ( 3 – 11 ), were characterized using spectroscopic methods. All isolates were tested for inhibitory effects on nitric oxide (NO) production in BV‐2 microglial cells. Compounds 1 , 6 , 7 , and 10 significantly reduced NO levels, with compounds 1 and 10 showing the strongest activity (IC 50 values of 3.57 ± 1.22 and 0.69 ± 0.18 µM, respectively). Western blot analysis confirmed the downregulation of inducible NO synthase protein, and molecular docking analysis revealed that compound 10 interacts with nuclear factor kappa‐light‐chain‐enhancer of activated B cells. These results highlight prenylated isoflavonoids from E. addisoniae as potential anti‐neuroinflammatory agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
- Department of Chemical Sciences, Center for Natural Product Research (CNPR), University of Johannesburg, Johannesburg, South Africa.
- Department of Organic Chemistry, Laboratory No. 3 of Organic Chemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
ORCID-Profile: Won Keun Oh
Förderung
- Basic Science Research Programs
- National Research Foundation of Korea
- Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT in Korea
Zitieren
APA
An, J. P., Seong, G. H., Che, Y., Ponce-Zea, J. E., Mai, V. H., Ndinteh, D. T., Mbafor, J. T., & Oh, W. K. (2026). New Prenylated Isoflavonoids From Erythrina addisoniae With Anti‐Neuroinflammatory Activity via Nuclear Factor Kappa‐Light‐Chain‐Enhancer of Activated B Cells Pathway Suppression. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202503261
Vancouver
An JP, Seong GH, Che Y, Ponce-Zea JE, Mai VH, Ndinteh DT, et al. New Prenylated Isoflavonoids From Erythrina addisoniae With Anti‐Neuroinflammatory Activity via Nuclear Factor Kappa‐Light‐Chain‐Enhancer of Activated B Cells Pathway Suppression. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202503261
BibTeX
@article{An2026,
author = {An, Jin-Pyo and Seong, Gi Hyeon and Che, YunHui and Ponce-Zea, Jorge-Eduardo and Mai, Van-Hieu and Ndinteh, Derek Tantoh and Mbafor, Joseph Tanyi and Oh, Won Keun},
title = {New Prenylated Isoflavonoids From Erythrina addisoniae With Anti‐Neuroinflammatory Activity via Nuclear Factor Kappa‐Light‐Chain‐Enhancer of Activated B Cells Pathway Suppression},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202503261}
}
EUVIMED